Germany Active Pharmaceutical Ingredients Market Size & Outlook

The active pharmaceutical ingredients market in Germany is expected to reach a projected revenue of US$ 11,394.3 million by 2030. A compound annual growth rate of 4.8% is expected of Germany active pharmaceutical ingredients market from 2024 to 2030.
Revenue, 2023 (US$M)
$8,228.4
Forecast, 2030 (US$M)
$11,394.3
CAGR, 2024 - 2030
4.8%
Report Coverage
Germany

Germany active pharmaceutical ingredients market, 2018-2030 (US$M)

Germany
Unlock Premium

Related Markets

Germany active pharmaceutical ingredients market highlights

  • The Germany active pharmaceutical ingredients market generated a revenue of USD 8,228.4 million in 2023 and is expected to reach USD 11,394.3 million by 2030.
  • The Germany market is expected to grow at a CAGR of 4.8% from 2024 to 2030.
  • In terms of segment, synthetic was the largest revenue generating type of synthesis in 2023.
  • Biotech is the most lucrative type of synthesis segment registering the fastest growth during the forecast period.


Active pharmaceutical ingredients market data book summary

Market revenue in 2023USD 8,228.4 million
Market revenue in 2030USD 11,394.3 million
Growth rate4.8% (CAGR from 2023 to 2030)
Largest segmentSynthetic
Fastest growing segmentBiotech
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSynthetic, Biotech
Key market players worldwideDr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, AbbVie Inc, Aurobindo Pharma, Sandoz Group AG Registered Shares, Viatris Inc, Fresenius Kabi


Other key industry trends

  • In terms of revenue, Germany accounted for 3.5% of the global active pharmaceutical ingredients market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany active pharmaceutical ingredients market is projected to lead the regional market in terms of revenue in 2030.
  • Spain is the fastest growing regional market in Europe and is projected to reach USD 5,744.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Active Pharmaceutical Ingredients Market Scope

Active pharmaceutical ingredients market segmentation & scope
Synthetic
Monoclonal Antibodies
Recombinant Proteins
Vaccines
Hormones
Cytokines
Therapeutic Enzymes
Blood Factors
Captive APIs
Biotech Merchant APIs
Synthetic Merchant APIs
Generic APIs
Innovative APIs
Cardiovascular Diseases
Oncology
CNS and Neurology
Orthopedic
Endocrinology
Pulmonology
Gastroenterology
Nephrology
Ophthalmology
Others
Prescription
OTC

Active Pharmaceutical Ingredients Market Companies

Name Profile # Employees HQ Website

Germany active pharmaceutical ingredients market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to active pharmaceutical ingredients market will help companies and investors design strategic landscapes.


Synthetic was the largest segment with a revenue share of 69.8% in 2023. Horizon Databook has segmented the Germany active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.


The presence of key market players in Germany and an increasing focus on geographic expansion with product launches are factors driving the API market in Germany. For instance, in May 2020, Evonik invested approximately USD 30 million to expand the capacity of its German API facility to meet the region's future API demands.

Germany is considered as a leader in API production in Europe. However, the country is reliant on Asia for 63% of its API raw material requirements. In February 2021, BioNTech announced its new production facility for mRNA, which is used as an API in COVID-19 vaccines in Marburg, Germany.

The facility is expected to be the largest in Europe and is projected to help produce over 750 million dosages of vaccine with mRNA. High demand for vaccines is expected to drive market growth in Germany in the coming years.

Reasons to subscribe to Germany active pharmaceutical ingredients market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Germany active pharmaceutical ingredients market databook

  • Our clientele includes a mix of active pharmaceutical ingredients market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Germany active pharmaceutical ingredients market , including forecasts for subscribers. This country databook contains high-level insights into Germany active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Germany active pharmaceutical ingredients market size, by type of synthesis, 2018-2030 (US$M)

Germany Active Pharmaceutical Ingredients Market Outlook Share, 2023 & 2030 (US$M)

Germany active pharmaceutical ingredients market size, by type of synthesis, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more